Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer.

Shabber Mohammed, Shabu Thakur, Diksha Manhas, Chilakala Nagarjuna Reddy, Abhisheik Eedara, Santosh K Guru, Ajeet Singh, Mahir Bhardwaj, Vaishnavi Kambhampati, Ramajayan Pandian, Boobalan Gopu, Shashi Bhushan, Ram A Vishwakarma, Sai Balaji Andugulapati, Shashank K Singh